分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

TGF-β-activated lncRNA LINC00115 is a critical regulator of glioma stem-like cell tumorigenicity

Jianming Tang, Bo Yu, Yanxin Li, Weiwei Zhang, Angel A Alvarez, Bo Hu, Shi-Yuan Cheng, Haizhong Feng

Journal:EMBO REPORTS

IF:8.38

DOI:10.15252/embr.201948170

PMID:

Published:2019-10-10

research field:肿瘤学神经科学分子生物学细胞生物学癌症生物学心血管生物学

Abstract

Long non‐coding RNAs (lncRNAs) are critical regulators in cancer. However, the involvement of lncRNAs in TGF‐β‐regulated tumorigenicity is still unclear. Here, we identify TGF‐β‐activated lncRNA LINC00115 as a critical regulator of glioma stem‐like cell (GSC) self‐renewal and tumorigenicity. LINC00115 is upregulated by TGF‐β, acts as a miRNA sponge, and upregulates ZEB1 by competitively binding of miR‐200s, thereby enhancing ZEB1 signaling and GSC self‐renewal. LINC00115 also promotes ZNF596 transcription by preventing binding of miR‐200s to the 5′‐UTR of ZNF596, resulting in augmented ZNF596/EZH2/STAT3 signaling and GBM tumor growth. Inhibition of EZH2 by genetic approaches or a small molecular inhibitor markedly suppresses LINC00115‐driven GSC self‐renewal and tumorigenicity. Moreover, LINC00115 is highly expressed in GBM, and LINC00115 expression or correlated co‐expression with ZEB1 or ZNF596 is prognostic for clinical GBM survival. Our work defines a critical role of LINC00115 in GSC self‐renewal and tumorigenicity, and suggests LINC00115 as a potential target for GBM treatment.

本文使用的Yeasen产品

购物车
客服
转染试用